Global Respiratory Tract Infection Treatment Overview
Respiratory tract infection is the infections related to the respiratory tract. Respiratory tract infection is generally classified in two type upper respiratory tract infection and lower respiratory tract infection.
High prevalence of respiratory tract infection in key regions such as U.S. and Europe is expected to significantly increase demand for respiratory tract infection treatment drugs and fuel its market growth over the forecast period of time. For instance, as per study published by World Health Organization in 2016, globally pneumonia is the largest infectious disease caused around 16% of all deaths of children under five years old.
According to the report published by Centers of Disease Control and Prevention (CDC) in 2017, in U.S. around 30.9Mn people suffered from influenza and around 14.5Mn went to healthcare facilities for influenza treatment, and an estimated 600,000 people being hospitalized from influenza.
Launches and approval of novel drugs for the treatment of different type of respiratory trach infections is expected to cater the market growth over the forecast period of time. For instance, in 2010, APP Pharmaceuticals, Inc., a Fresenius Kabi Pharmaceuticals Holding, Inc., company received U.S. Food and Drug Administration (FDA) approval to market AztreonamInjection, USP, equivalent to the reference-listed drug Azactam(R), which is marketed by Bristol-Myers Squibb. The drug is indicated for the treatment of lower respiratory tract infectionscaused by susceptible gram-negative microorganisms.
The respiratory tract infection treatment market has been segmented on the basis of drug class, disease indication, distribution channel, and region.
On the basis of drug class, the respiratory tract infection treatment market has been segmented in cough suppressant, nasal decongestant, antibiotics, non-steroidal anti-inflammatory drug (nsaids), and others.
On the basis of disease indication the Respiratory tract infection treatment market has been segmented in upper respiratory tract infection and lower respiratory tract infection.
On the basis of distribution channel, the respiratory tract infection treatment market has been segmented in retail pharmacies, online pharmacies, and hospitals.
On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.
Key players operating in the respiratory tract infection treatment market includes, Abbvie Inc., CiplaLtd, Abbott Laboratories, AstraZeneca, Plc, BoehringerIngelheim GmbH, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.
Global Respiratory Tract Infection Treatment Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Abuse Type
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Pipeline Analysis
- Merger and Acquisitions
- Recent Approvals
- Epidemiology
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Market Segmenataion, Abuse Type, 2018 – 2029, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Opioid Addiction
- Introduction
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Alcohol Dependence
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Tobacco/Nicotine Addiction
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Market Segmenataion, By Drug Type, 2018 – 2029, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Disulfiram
- Introduction
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Acamprosate
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Bupropion
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Varenicline
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Naltrexone
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Buprenorphine
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Nicotine Replacement Treatment
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
Ø Nicotine Patch
§ Overview
§ Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
Ø Nicotine Gum
§ Overview
§ Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
Ø Nicotine Lozenge
§ Overview
§ Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
Ø Nicotine Spray
§ Overview
§ Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
Ø Nicotine Inhaler
§ Overview
§ Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Market Segmenataion, By Distribution Channel, 2018 – 2029, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Retail Pharmacies
- Introduction
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Online Pharmacies
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Hospitals
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others
§ Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Global Market, By Region, 2018 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
- Overview
Ø U.S.
Ø Canada
- Europe
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
Ø Germany
Ø UK
Ø France
Ø Russia
Ø Italy
Ø Switzerland
Ø Sweden
Ø Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
Ø China
Ø India
Ø Australia & New Zealand
Ø Japan
Ø South Korea
Ø Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
Ø Brazil
Ø Mexico
Ø Argentina and Chile
Ø Rest of Latin America
- Middle East
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
Ø GCC
Ø Israel
Ø Rest of Middle East
- Africa
- Market Size and Forecast (US$ Mn), By Abuse Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Drug Type, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
Ø South Africa
Ø Central Africa
Ø North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Pfizer Inc.*
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Market Strategy
- Mylan N.V.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Cipla Limited
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Odyssey Pharmaceuticals Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Teva Pharmaceutical Industries Ltd.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Glenmark Pharmaceuticals
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Lil\' Drug Store Products Inc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Dr. Reddy\'s Laboratories
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Indivior Plc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- British American Tobacco Plc.
Ø Company Overview
Ø Product Portfolio
Ø Key Highlights
Ø Financial Overview
Ø Business Strategy
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
Respiratory Tract Infection Treatment Market accounted for US$ 43171.87 million in 2020 and is estimated to be US$ 83137.85 million by 2030 and is anticipated to register a CAGR of 6.8%
Emerging trends include the development of new antibiotics, the rise of combination therapies, and the exploration of antiviral drugs for respiratory infections. Opportunities arise from the increasing incidence of respiratory tract infections, advancements in treatment options, and the potential for targeted therapies against specific pathogens.
Respiratory Tract Infection Treatment market is segmented into drug class, disease indication, distribution channel, end-user and region.
Regions covered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the market due to a well-established healthcare infrastructure, high prevalence of respiratory infections, and significant investments in infectious disease research. However, the Asia-Pacific region is experiencing notable growth, driven by increasing healthcare awareness, a large population at risk of respiratory infections, and the expansion of pharmaceutical markets in countries like China and India.
Key factors include the continuous prevalence of respiratory tract infections, the emergence of drug-resistant strains, advancements in diagnostic technologies allowing for targeted treatments, and the impact of environmental factors on respiratory health. Additionally, the ongoing research and development in infectious disease therapeutics contribute to market growth.
The key players in the Respiratory Tract Infection Treatment market includes Abbvie Inc., CiplaLtd, Abbott Laboratories, AstraZeneca, Plc., BoehringerIngelheim GmbH, GlaxoSmithKline plc., Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.